BiotechTube
Home/Rivus Pharmaceuticals/David Grainger, Ph.D.
DG

David Grainger, Ph.D.

Chair of Development and Co-Chair of the Board

Rivus Pharmaceuticals

Therapeutic Areas

Metabolic DiseasesObesityMASHCardiometabolic Diseases

Rivus Pharmaceuticals Pipeline

DrugIndicationPhase
HU6MASLD, MASH, HFpEF in obesityPhase 2
RV-8451ObesityPreclinical

Leadership Team at Rivus Pharmaceuticals

JB
Jorge Bartolome
Chief Executive Officer
AC
Allen Cunningham
Chief Operating Officer
SK
Shaharyar Khan, Ph.D.
Chief Scientific Officer
MF
Meg Fitzgerald, J.D.
Chief Legal Officer
View full Rivus Pharmaceuticals profile